Gland Pharma gets USFDA approval for fertility treatment injection
Gland Pharma receives approval for cetrorelix acetate for injection
By Madhu Balaji
Gland Pharma receives USFDA approval for Cetrorelix Acetate for Injection
Gland Pharma bags USFDA nod for Cetrorelix Acetate for Injection
By Ruchika Sharma and Kamal Kohli
Full coverage of this story
US FDA gathering information on MDH and Everest spice products amidst carcinogenic pesticide concerns
'We do not use ethylene oxide': MDH refutes cancer-causing pesticide allegations
US Customs Rejected Nearly One-Third Of MDH's Spice-Related Shipments In Last 6 Months: Here's Why
Trouble for Indian spices in US: Health officials swoop in amid contamination allegations
US rejects 1/3rd of MDH exports since October over salmonella
By Aggam Walia
Full coverage of this story
Pfizer’s one-time haemophilia B therapy Beqvez granted FDA approval
By Emily Kimber
Pfizer scores FDA nod for hemophilia B gene therapy, will charge $3.5M per dose
By Kevin Dunleavy
US approves gene therapy treatment for hemophilia
U.S. FDA Approves Pfizer's BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B
Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B
Full coverage of this story
Glenmark Pharma receives USFDA nod for generic anti-inflammatory drug
Glenmark Pharma gets USFDA nod for Acetaminophen and Ibuprofen tablets
Glenmark Pharma gets USFDA nod for generic anti-inflammatory drug
Glenmark Pharmaceuticals receives ANDA approval for acetaminophen and ibuprofen tablets
By Madhu Balaji
Glenmark Pharma shares gain on US FDA nod for acetaminophen, ibuprofen tablets
Full coverage of this story
Nashik: FDA Raids Sweet Shops at Saptashringi Garh, Seizes Over ₹5 Lakh Worth of Adulterated Sweets
By Prashant Nikale
Lupin receives Establishment Inspection Report from USFDA for its Aurangabad manufacturing facility
Full coverage of this story
Zydus Lifesciences shares slip 4% as USFDA issues 10 observations for Gujarat unit
By Aseem Thapliyal
Zydus Lifesciences receives USFDA approval for acne treatment cream
Zydus Lifesciences bags USFDA nod for acne cream Tretinoin
By Ruchika Sharma and Kamal Kohli
Zydus Life drops 4% after US FDA's 10 observations for Vadodara unit
Zydus Lifesciences' injectable manufacturing site concludes USFDA inspection
Full coverage of this story
Natco Pharma gets EIR from USFDA on pharmacovigilance requirements
Full coverage of this story
Lupin rises over 3% after US FDA approves Mirabegron tablets
Full coverage of this story
US FDA says about 1 in 5 commercial milk samples tested positive for bird flu traces
By Srishty Choudhury
Full coverage of this story
USFDA issues Form 483 with five inspectional observations to Marksans Pharma's Goa unit
Import alerts, warning letters, drug recalls — why ‘pharmacy to the world’ is facing US FDA heat
By Sumi Dutta
Marksans Pharma drops over 3% as USFDA issues five observations after inspection at Goa facility
Marksans Pharma declines after US FDA issues Form 483 with 5 observations to Goan plant
Marksans Pharma Goa manufacturing facility gets five inspectional observations from USFDA
By Shloka Badkar
Full coverage of this story
Jubilant gets VAI classification from USFDA for Roorkee unit
Full coverage of this story
US FDA releases details of OAI observations at Sun Pharma’s Dadra plant
By Neethi Lisa Rojan
Sun Pharma-FDA: Regulatory Concerns At Dadra facility Can Dent Sentiment, Say Analysts
By Maitri Seth
Sun Pharma: 2 key reasons why HSBC expects 16% upside despite regulatory woes
By Ujjval Jauhari
Another regulatory blow for Sun Pharma after Dadra unit tagged 'OAI' by US FDA, stock down
By Vaibhavi Ranjan
Full coverage of this story
FDA Accepts Dermavant's sNDA for Tapinarof Cream 1% for Adults and Children With AD
By Kaitlyn Bader
Clinician and Patient Perspective: Tapinarof Cream for Plaque Psoriasis
By Kaitlyn Bader and Mona Shahriari
Full coverage of this story
NKGen Biotech Shares Rise 15% After FDA Clears Application for Parkinson's Disease Therapy
By Chris Wack
Full coverage of this story
Sun Pharma slips 3% after OAI status from USFDA for Dadra facility
By Deepak Korgaonkar
Lawmakers Urge VA To Prepare Strategy For MDMA Therapy As FDA Weighs Approval
By David Carpenter
Full coverage of this story
Alkem CFO: USFDA observations at Baddi plant mainly procedural, no data integrity issues
By Nigel D'Souza
Full coverage of this story
USFDA inspection of Lupin’s Dabhasa Facility completed; No observations reported
Buy Lupin; target of Rs 1868: Sharekhan
Lupin gains as USFDA completes inspection at Gujarat facility with zero observation
Lupin gains after USFDA concludes inspection at Gujarat facility with no observations
USFDA concludes inspection of Lupin Dabhasa facility with no observations
By Ruchika Sharma and Kamal Kohli
Full coverage of this story
USFDA issues 'warning letter' to Kilitch Healthcare over GMP violation
By Sanket Koul
USFDA issues warning letter to Kilitch Healthcare for Navi-Mumbai plant
The FDA serves up warning letters to pair of Indian pharmas
By Fraiser Kansteiner
Natco Pharma Kothur facility gets USFDA warning letter
By Ruchika Sharma and Kamal Kohli
U.S. FDA issues warning letter to Natco over facility near Hyderabad
Full coverage of this story
Glenmark, Lupin recalling drugs in American market: USFDA
Glenmark recalls 6528 bottles of blood pressure drug after samples fail quality test
Glenmark recalls 6528 bottles of high blood pressure medicines in US market
By Jocelyn Fernandes
Glenmark Pharma recalls 6528 bottles of BP drug in US
By Ruchika Sharma
Lupin, Glenmark, Natco recall products from US markets
By Neethi Lisa Rojan
Full coverage of this story
Celltrion USA signs agreement with Express Scripts for its therapy for autoimmune diseases including the first FDA-approved subcutaneous infliximab ZYMFENTRA™
Celltrion’s Zymfentra included in Express Scripts’ preferred formulary in US
Celltrion USA signs agreement with Express Scripts for its therapy for autoimmune diseases including the first FDA-approved subcutaneous infliximab ZYMFENTRA
Celltrion USA signs agreement with Express Scripts for its therapy for autoimmune diseases
Full coverage of this story
Agony over ecstasy: FDA bid shows it's hard to test psychedelics
By Daniel Gilbert and David Ovalle
Ecstasy’s bid for FDA approval reveals challenges of psychedelic trials
By Daniel Gilbert and David Ovalle
From politics to the lab: The push for psychedelics in Mass.
By Deborah Becker
Full coverage of this story
Lupin gets USFDA nod to market generic medication
Pharma stock jumps 2.4% after announcing the launch of the first generic version of Oracea capsules in the United States.
Lupin gets approval for generic Ingrezza, launches generic Oracea
By Sandra Levy
Lupin Shares Gain 2% on Launching Doxycycline Capsules in US
Lupin launches Doxycycline capsules in United States | Capital Market News
Full coverage of this story
Provisio Medical announces US FDA clearance of the Provisio SLT IVUS system
Full coverage of this story
Despite Lack of Benefit and Increased Suicidality, FDA Approved Lexapro for Seven-Year-Olds
By Peter Simons
FDA, CDC warn of side effects from fake Botox after 11 patients hospitalized
Full coverage of this story
Partisan Politics Returns To US FDA Congressional Oversight
By Michael Mccaughan
Yoghurt reduces the risk of Type 2 Diabetes – says FDA
Daily Yogurt Consumption: A Solution for Prediabetes? Experts Reveal | TheHealthSite.com
Nutritionist praises 33p food that 'curbs appetite and aids weight loss'
Specific probiotic strain in yogurt may improve glycemic control in individuals with prediabetes: Study
By Kamal Kohli and Jacinthlyn Sylvia
Healthy 33p food that 'curbs appetite and aids weight loss', according to nutritionist
Full coverage of this story
FDA Says Vaccination Is the Best Protection Against Measles
Full coverage of this story
Lupin bags tentative USFDA nod for Migalastat Capsules
By Ruchika Sharma and Kamal Kohli
Henlius Trastuzumab Receives FDA Approval in the United States
Full coverage of this story
Rep. Robin Kelly and Gwen Carr, mother of Eric Garner Respond to FDA Abandoning Menthol Cigarette Ban
Biden administration indefinitely postpones rule that would have banned menthol-flavoured cigarettes
Biden Administration Delays Proposed Menthol Cigarettes Ban
By Cailey Gleeson
NAACP Condemns White House on Abandoning Menthol Ban
Biden administration delays proposed ban on menthol cigarettes
By Carma Hassan and Kevin Liptak
Full coverage of this story
FDA approves adjustable spine pain implant
Advances in AI — April 2024
By Jeff Hall
Medtronic snags FDA approval for body-sensing, closed-loop spinal cord stimulator
By Conor Hale
FDA approves new spinal-cord device for chronic pain, Medtronic says
By Daniel Gilbert and David Ovalle
Medtronic bags FDA approval for Inceptiv spinal cord stimulator
By Joshua Silverwood
Full coverage of this story